If patients experience intolerable side effects at a given dose, maintaining the current dose for an additional 4 weeks or temporarily reducing the dose may improve tolerance before attempting further escalation
In the central nervous system, GLP-1s may impact neuronal function in conditions, such as Alzheimer's disease and Parkinson's disease, through multiple mechanisms
Monitoring combination effects: Track both conventional metrics (intraocular pressure, HbA1c) and peptide-relevant outcomes (visual field, OCT thickness, symptom improvements)
Clinically, we often observe that oral BPC-157 offers superior outcomes for patients with GI inflammation, bloating, food sensitivities, or irritable bowel symptoms
Tesofensine is a potent norepinephrine, dopamine, and serotonin reuptake inhibitor that helps regulate appetite and boost energy expenditure
Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease